Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
- 18 December 2018
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 276 (2) , 575-583
Abstract
We aimed to analyze the oncological and functional outcomes of chemoradiation for T4 laryngeal and hypopharyngeal cancer.Keywords
This publication has 22 references indexed in Scilit:
- Persistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancerHead & Neck, 2013
- Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapyEuropean Archives of Oto-Rhino-Laryngology, 2013
- Functional Outcomes of Chemoradiation in Patients with Head and Neck CancerOtolaryngology–Head and Neck Surgery, 2012
- Comparison of quality of life in advanced laryngeal cancer patients after concurrent chemoradiotherapy vs total laryngectomyOtolaryngology–Head and Neck Surgery, 2008
- Quality of Life for Patients Following Total Laryngectomy vs Chemoradiation for Laryngeal PreservationJAMA Otolaryngology–Head & Neck Surgery, 2004
- Clinical Predictors of Quality of Life in Patients With Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2004
- Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: Results of single-center study of 45 patientsHead & Neck, 2004
- An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck CancerJournal of Clinical Oncology, 2003
- Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neckCancer, 2002
- Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III TrialJNCI: Journal of the National Cancer Institute, 1996